Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters

Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012

Volumn , Issue , 2012, Pages 534-538

  Wang, Mengjun ^a   Block, Timothy M ^a   Marrero, Jorge ^b   Di Bisceglie, Adrian M ^c   Devarajan, Karthik ^d   Mehta, Anand ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

biomarkers; classification and regression trees; Hepatitis B virus; Hepatocellular Carcinoma; logistic regression; penalized logistic regression

Indexed keywords

CLASSIFICATION AND REGRESSION TREE; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; LOGISTIC REGRESSIONS; PENALIZED LOGISTIC REGRESSION;

BIOINFORMATICS; LOGISTICS; REGRESSION ANALYSIS; VIRUSES;

BIOMARKERS;

EID: 84872504787     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBM.2012.6392612     Document Type: Conference Paper

References (14)

1. Di Bisceglie, A.M., Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med Clin North Am, 1989. 73(4): p. 985-97.
2. Block, T.M., A.S. Mehta, C.J. Fimmel, and R. Jordan, Molecular viral oncology of hepatocellular carcinoma. Oncogene, 2003. 22(33): p. 5093-107.
3. Marrero, J.A., Hepatocellular carcinoma. Curr Opin Gastroenterol, 2006. 22(3): p. 248-53.
4. Sallie, R. and A.M. Di Bisceglie, Viral hepatitis and hepatocellular carcinoma. Gastroenterol Clin North Am, 1994. 23(3): p. 567-79.
5. Alpert, M.E., J. Uriel, and B. de Nechaud, alpha fetogloblin in the diagnosis of human hepatoma. N Engl J Med, 1968. 278: p. 984-6.
6. Ruoslahti, E., M. Salaspuro, H. Pihko, L. Andersson, and M. Seppala, Serum alpha-fetoprotein: diagnostic significance in liver disease. Br Med J, 1974. 2(918): p. 527-9.
7. Di Bisceglie, A.M. and J.H. Hoofnagle, Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer, 1989. 64(10): p. 2117-20.
8. Sherman, M., Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis, 2005. 25(2): p. 143-54.
9. Comunale, M.A., Lowman, M., Long, R.E., Krakover, J., Philip, R., Seeholzer, S., Evans, A. A., Hann, H.W.L, Block, T.M, Mehta, A.S, Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. Journal of Proteome Research., 2006. 6(5): p. 308- 315.
10. Wang, M., R.E. Long, M.A. Comunale, O. Junaidi, J. Marrero, A.M. Di Bisceglie, T.M. Block, and A.S. Mehta, Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev, 2009. 18(6): p. 1914-21.
11. Marrero, J.A., P.R. Romano, O. Nikolaeva, L. Steel, A. Mehta, C.J. Fimmel, M.A. Comunale, A. D'Amelio, A.S. Lok, and T.M. Block, GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005. 43(6): p. 1007-12.
12. Park, M.Y. and T. Hastie, Penalized logistic regression for detecting gene interactions. Biostatistics, 2008. 9(1): p. 30-50.
13. Team, R.D.C., R: A language and environment for statistical computing. , in R Foundation for Statistical Computing 2005. p. URL http://www.R-project.org.
14. Hothorn, T., K. Hornik, and A. Zeileis, Unbiased recursive partitioning: A conditional inference framework. Journal of Computational and Graphical Statistics, 2006. 15(3).